CCCCc1c(O)nc(SC2CC(=O)N(c3ccc(C(=O)OCC)cc3)C2=O)nc1O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?